ARTICLE | Financial News
Icos sells follow-on
December 14, 2000 8:00 AM UTC
ICOS, which is developing small molecule and protein-based therapeutics to treat a variety of diseases, raised $166.5 million through the sale of 4.5 million shares at $37, in a follow-on underwritten...